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 Introduction 
 The perfect surgical technique for radical prostatec-
tomy (RP) in localized disease should have minimal peri-
operative morbidity and completely remove the prostate 
with tumor-negative margins while preserving urinary 
continence and erectile function. However, attaining the 
best possible outcome in one might compromise the oth-
er. Over the last years, robot-assisted laparoscopic RP 
(RALRP) has become a well-established procedure for 
the management of localized prostate cancer with onco-
logic and functional results comparable to open retropu-
bic RP and laparoscopic RP (LRP)  [1–4] . RALRP offers 
magnification and improved visualization of the surgical 
site. This might facilitate the exploration of the neurovas-
cular bundles (NVBs) and may allow a more accurate dis-
section of the fascial layers.
 Intrafascial nerve-sparing (INS) is characterized by a 
preparation close to the prostatic capsule (PC) with the 
intention to preserve nerve fibers on the lateral surface of 
the prostate, which are known to play a significant role in 
neural stimulation to the cavernous tissue  [5–7] . Im-
proved potency and continence rates after RP with INS 
have been reported  [8, 9] . However, the close preparation 
to the prostate might result in an incomplete resection 
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 Abstract 
 Introduction: Improved visualization and magnification in 
robot-assisted laparoscopic radical prostatectomy (RALRP) 
has tempted many urologists to dissect the neurovascular 
bundle closer to the prostate following the layers of the 
pseudo-capsule of the prostate. This might bear a higher risk 
of decreased tumor control.  Materials and Methods: An 
analysis of a consecutive series of 186 patients who under-
went RALRP at our institution was performed. The outcome 
of patients with intrafascial nerve-sparing (INS) was com-
pared with the outcome of patients who underwent inter-
fascial, extrafascial or no nerve-sparing (non-INS).  Results: A 
total of 80 patients (43.0%) received INS. The overall R1 rate 
was 27.9%. For pT2 tumors the rate of R1 was 33.8% in INS 
versus 14.8% in non-INS (odds ratio 2.936, 95% confidence 
interval 1.338–6.443, p = 0.007). Recurrence-free survival 
was significantly shorter in INS (p = 0.05; hazard ratio 3.791). 
 Conclusion: The intrafascial dissection technique for RALRP 
bears a high risk of incomplete resection in localized pros-
tate cancer resulting in unfavorable outcome. 
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bearing the risk of a higher rate of positive surgical mar-
gins (PSMs). The correlation between PSM and biochem-
ical failure risk is well established  [10, 11] . Therefore, the 
primary goal of RP is complete tumor control with nega-
tive margins.
 In previous publications, INS was correlated with 
functional outcome and/or PSM rates with no  [9, 12–
14] or only short-term oncological outcome  [15–17] . In 
this study we have investigated the influence of INS in 
RALRP on recurrence-free survival (RFS), PSM rates, lo-
cation of PSMs, and compared this approach to other 
techniques of RALRP performed in our institution.
 Materials and Methods 
 Patient Selection 
 The charts of 186 consecutive patients with prostate cancer 
who underwent RALRP in the Department of Urology at the Uni-
versity Hospital Zürich between May 2006 and August 2008 were 
reviewed retrospectively. Only patients operated by surgeons with 
high caseloads ( 1 50) were included in this study. Peri- and post-
operative data including the surgical technique, clinical and path-
ological data were collected. Operation time included RALRP and 
lymphadenectomy if performed without an individual time mea-
surement of the two procedures. Patients with intrafascial ap-
proach were designated as INS, whereas all other gradations of 
more lateral preparations were considered as no nerve-sparing 
(non-INS). No patient received preoperative androgen depriva-
tion. Approval was received from the internal review board.
 Surgical Technique 
 Three senior urologists performed the RALRPs using the 
three-arm da Vinci System  (Intuitive Surgical Inc., Sunnyvale, 
Calif., USA). The minimum requirement for the intrafascial ap-
proach was a biopsy Gleason score of  ^  7 and prostate cancer in 
less than 50% of the biopsy cores. A unilateral intrafascial dissec-
tion of the NVB was performed on the side without positive biop-
sies or palpable nodules.
 The surgical procedure was performed by all three surgeons 
as follows: If necessary, a bilateral extended pelvic lymphadenec-
tomy was done. Afterwards the ligation of the Santorini plexus 
was performed. Following dissection of the bladder neck in a 
straight line down to the pillars, the seminal vesicles were re-
moved completely. If the patient received a nerve-sparing, prepa-
ration of the NVB was performed without coagulation in order to 
avoid thermal damage of the nerve fibers.
 For an INS, the lateral release of the NVB started at the poste-
rior surface of the prostate, leaving all lateral layers intact. After 
incision of the Denonvilliers’ fascia (DF) a blunt separation of the 
prostate and the NVB was performed. The preparation was fin-
ished by further dissection directed medially reaching the ante-
rior surface of the prostate. The plane was developed between the 
PC and its overlaying periprostatic fascia (PF). The correct plane 
of dissection is recognized when the surface of the prostate is 
smooth and reflecting. The inter- and extrafascial approaches 
were performed at the lateral aspect of the prostate laterally to the 
PF leaving it intact; the dissection began inside/medial of the an-
terior extension of the DF (interfascial) or outside/lateral of it (ex-
trafascial/non-INS) ( fig. 1 ).
 After careful preparation of the apex, the prostate was released 
and finally the vesicourethral anastomosis was performed with 
interrupted sutures.
 Pathological Evaluation 
 Tumor stage, Gleason score and surgical margin status were 
retrieved from the pathological report from the Institute of Clin-
ical Pathology of the University Hospital Zürich. Detailed com-
prehensive pathologic analysis was performed using standardized 
whole-mount sections. If tumor cells were detectable at the inked 
surface, the surgical margins were considered positive. The sites 
of PSMs (apex, bladder neck, posterior/lateral surface) were as-
sessed.
 Oncological Outcome 
 Clinical follow-up data were collected for all patients. Patients 
were routinely assessed using a PSA test after 6 weeks, 6 and 
12 months, and yearly thereafter. Time to PSA recurrence was se-
lected to assess the oncological outcome (RFS). PSA recurrence 
was defined as PSA value  6 0.1 ng/ml with consecutive confirma-
nvb
df
pc
pf
ef
sp
 Fig. 1. Three-dimensional schematic depiction of the prostate: 
anatomic relations of prostate, endopelvic fascia (ef), peripros-
tatic fascia (pf), Denovilliers’ fascia (df) and neurovascular bun-
dle (nvb). The arrow indicates the correct layer for intrafascial 
dissection. sp = Santorini plexus; pc = prostatic capsule. 
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tion after reaching a PSA nadir  ^  0.1 ng/ml postoperatively. Pa-
tients not reaching PSA nadir ( ! 0.1 ng/ml) postoperatively were 
excluded for RFS analysis because metastatic disease could not be 
excluded.
 Learning Curve 
 To investigate the relation of surgeon’s experience with PSMs, 
the rate in pT2 disease was calculated for 3-month time segments 
( fig.  2 e). Additionally, to analyze the connection to the nerve-
sparing technique, the rate of INS was also calculated over time.
 Statistical Analysis 
 PASW version 18.0 (SPSS, Chicago, Ill., USA) was used for sta-
tistical analyses. Contingency table analysis and   2 tests were 
used to assess statistical associations between clinicopathological 
data and surgical technique for categorical and grouped variables. 
For comparison of means the independent-samples t test was per-
formed. Kaplan-Meier estimates were computed for RFS and were 
compared between the two groups using the log-rank test. Pa-
tients were censored at the time of first PSA recurrence. A multi-
variable Cox regression model was adjusted, testing the indepen-
dent prognostic relevance of the surgical technique. Pearson cor-
relation was used to evaluate the statistical correlation between 
PSM and INS. All p values  ^  0.05 were considered significant.
 Results 
 Descriptive Analysis 
 A total of 80 patients (43.0%) received a RALRP with 
INS. 106 patients were operated with a more lateral prep-
aration (non-INS). In INS, 57.5% (n = 46) received nerve-
sparing on both sides whereas only 23.6% (n = 25) in non-
INS did.
 Patients in INS were significantly younger (62.55 vs. 
64.86, p = 0.014) and had a lower BMI (25.57 vs. 26.44, 
p = 0.061). Further, the biopsy Gleason score (70%  ^  6 vs. 
48%  ^  6, p  ! 0.003) and preoperative PSA (7.16 vs. 11.53, 
p = 0.001) were significantly lower. For perioperative pa-
tient characteristics, see  table 1 .
 Pathologic Evaluation 
 Gleason score distribution was significantly different 
between INS and non-INS (38%  ^  6 vs. 23.6%  ^  6, p = 
0.020). Evaluation of the specimen revealed that 152 pa-
tients (81.7%) had a pT2 and 34 patients (18.3%) a pT3 tu-
mor. The diagnosis of a pT3 tumor was made in 11.3% of 
cases in INS and in 23.6% of cases in non-INS (p = 0.023).
 Univariate analysis showed that INS was a significant 
predictive factor for PSMs in pT2 tumors (33.8 vs. 14.8%; 
odds ratio (OR) 2.936, 95% confidence interval (CI) 
1.338–6.443, p = 0.007;  table 1 ) but not for pT3 tumors 
(OR 0.867, 95% CI 0.187–4.007, p = 0.855). The majority 
of PSMs in pT2 tumors was found at the apex (44.4%) 
with no significant difference between the two groups (50 
vs. 33.3%, p = 0.389;  table 1 ). For pT3 tumors, the major-
ity of PSMs (62.5%) had a multifocal location (p = 0.209). 
No difference for PSMs comparing different surgeons 
and nerve-sparing technique could be observed (data not 
shown).
 Figure 2 e represents the percentage of PSMs for pT2 
tumors over time. Our data failed to demonstrate a de-
crease of the PSM rate over the study period of 27 months. 
A significant positive correlation between PSM rates and 
percentage of INSs performed was maintained over time 
(Pearson correlation 0.846, p = 0.004).
 Oncological Outcome 
 Follow-up data were available for 136 of 152 patients 
(89.4%) in the pT2 cohort and for 34 patients (100%) in 
the pT3 cohort. Median follow-up of both cohorts was 
24 months (range 0–45). Ten patients not reaching nadir 
( ^  0.1 ng/ml) postoperatively were excluded for RFS anal-
ysis. Univariate Cox regression analysis ( table 2 ) and Ka-
plan-Meier analysis ( fig. 2 a, b) revealed that RALRP with 
INS as well as PSMs were significantly associated with 
shorter RFS in pT2 tumors (hazard ratio (HR) 3.791, p = 
0.05 and HR 7.045, p = 0.002, respectively). The multi-
variate analysis for RFS ( table 2 ) showed a HR for INS of 
5.363 (p = 0.045, 95% CI 1.039–27.680) and for PSMs of 
6.268 (p = 0.006, 95% CI 1.697–23.149), respectively. No 
such effect could be observed for pT3 tumors ( table  2 ; 
 fig. 2 c, d).
 Discussion 
 Nearly 30 years ago, Walsh and Donker  [18] first de-
scribed a nerve-sparing RP, which increased the accep-
tance of the operation to patients, referring physicians 
and surgeons. For many years, the open RP remained the 
standard for treatment of patients with a localized dis-
ease. In an effort to further decrease the morbidity, a 
minimally invasive surgical approach to treating prostate 
cancer (i.e. LRP) was first described in 1997 by Schuessler 
et al.  [19] . The introduction of LRP and later RALRP of-
fered additional magnification and improved visualiza-
tion of the surgical site allowing urologists to rediscover 
the prostatic anatomy. The better distinction of the fi-
brous layers made different approaches to these fascial 
planes possible  [8, 20] .
 A novel surgical technique suggested by Stolzenburg 
et al.  [8] with the goal of improved nerve-sparing was the 
intrafascial preparation. This technique requires a per-
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 Fig. 2.  a–d Kaplan-Meier curves showing RFS of prostate cancer 
patients with pT2 ( a ,  b ) and pT3 ( c ,  d ) disease who underwent 
RALRP with INS versus patients with other techniques ( a ,  c ) and 
with PSM status versus negative surgical margin status ( b ,  d ). 
 e Cumulative bar chart representing percentage of intrafascial 
prostatectomies and percentage of PSMs in pT2 disease subdi-
vided for 3-month time segments starting May 2006. 
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fect exposure of the anatomical layers surrounding the 
prostate to remove the prostate without periprostatic tis-
sue. Three fibrous layers surrounding the prostate can be 
individualized during RALRP  [21] . The endopelvic fas-
cia, the PF and the DF cover the prostate gland and form 
the periprostatic environment ( fig. 1 ). INS is considered 
a dissection that follows a plane on the PC and runs under 
the PF. It also remains anterior to the DF. The interfascial 
approach, in contrast, is performed outside or laterally to 
the PF at the antero- and posterolateral aspects of the 
prostate. The PF remains intact and is removed with the 
prostate  [22] . In the extrafascial approach the dissection 
Table 1. Perioperative patient characteristics and positive surgical margins
Total cohort
(n = 186)
INS:
intrafascial
(n = 80)
Non-INS:
inter-/extrafascial,
no nerve-sparing
(n = 106)
p* Test
type
Preoperative data
Age, years 63.8786.37 62.5586.82 64.8685.86 0.014 t test
Body mass index, kg/m2 26.0683.14 25.5783.16 26.4483.10 0.061 t test
Preoperative PSA, ng/ml 9.6488.61 7.1683.60 11.53810.64 0.001 t test
Gleason biopsy score 0.003 2
5–6 107/186 (57.5%) 56/80 (70.0%) 51/106 (48.1%)
7 67/186 (36.0%) 23/80 (28.7%) 44/106 (41.5%)
8–10 12/186 (6.5%) 1/80 (1.3%) 11/106 (10.4%)
Intraoperative data
Operation time, min 241.76879.15 213.15870.49 263.35878.77 <0.001 t test
Estimated blood loss, ml 513.328466.60 450.508341.31 558.408541.39 0.121 t test
Hemoglobin preoperative, g/dl 14.7281.22 14.7381.26 14.7281.19 0.963 t test
Hemoglobin postoperative, g/dl 11.2181.53 11.1681.55 11.2581.53 0.706 t test
Transfusion rate 11/186 (5.9%) 8/80 (10%) 3/106 (2.8%) 0.041 2
Postoperative data
Hospital stay, days 7.4984.47 6.8982.70 7.9485.40 0.111 t test
Complication rate 27/186 (14.5%) 7/80 (8.8%) 20/106 (18.9%) 0.052 2
Gleason score 0.020 2
5–6 55/185 (29.7%) 30/79 (38%) 25/106 (23.6%)
7 103/185 (55.7%) 43/79 (54.4%) 60/106 (56.6%)
8–10 27/185 (14.6%) 6/79 (7.6%) 21/106 (19.8%)
pT stage 0.023 2
pT2a–c 152/186 (81.7%) 71/80 (88.7%) 81/106 (76.4%)
pT3ab 34/186 (18.3%) 9/80 (11.3%) 25/106 (23.6%)
Median follow-up, months (median) 23 (0–45) 23 (1–42) 24 (0–45)
pT2 tumors      
Positive surgical margins, R1 36/152 (23.8%) 24/71 (33.8%) 12/81 (14.8%) 0.007 2
Location of positive surgical margins 0.389 2
Apex 16/36 (44.4%) 12/24 (50%) 4/12 (33.3%)
Posterior/lateral 10/36 (27.8%) 7/24 (29.2%) 3/12 (25.0%)
Bladder neck 4/36 (11.1%) 1/24 (4.2%) 3/12 (25.0%)
Multifocal 6/36 (16.7%) 4/24 (16.7%) 2/12 (16.7%)
pT3 tumors 
Positive surgical margins, R1 16/34 (47.1%) 4/9 (44.4%) 12/25 (48.0%) 0.855 2
Location of positive surgical margins 0.209 2
Apex 2/16 (12.5%) 1/4 (25%) 1/12 (8.3%)
Posterior/lateral 3/16 (18.8%) 2/4 (50%) 1/12 (8.3%)
Bladder neck 1/16 (6.3%) 0/4 (0%) 1/12 (8.3%)
Multifocal 10/16 (62.5%) 1/4 (25%) 9/12 (75%)   
Data are means 8 SD or numbers unless otherwise mentioned. * p values ≤0.05 are marked in bold. 
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is outside or lateral of the anterior extension of the DF. In 
this plane a partial or no preservation of the NVB can be 
performed  [23] .
 The intrafascial approach has the potential to spare 
more nerve fibers but also increase the risk of higher PSM 
rates. In the present investigation we found an OR of 
2.936 for PSMs and a HR of 3.791 for RFS comparing INS 
versus non-INS in pT2 disease. Considering the clinical 
impact of a positive margin status on cancer recurrence 
 [10, 11] , the oncological safety of this procedure has to be 
called into question. The current level of PSM rates for all 
techniques (pT2 tumors, RALRP) has been reported as 
2.5–18% (mean 9.6% [for recent review, see  24 ]) and for 
the intrafascial technique (pT2, open RP, LRP, RALRP) 
4.5–21.9%  [9, 12–17, 25] . In this context, our PSM rate in 
pT2 disease for INS is surprisingly high with 33.8% while 
our PSM rate for other techniques is tolerable compared 
to other initial series described for RALP (14.8% in non-
INS, pT2  [24] ).
 In this research a significant shorter RFS in INS (pT2) 
could already be demonstrated at a median follow-up of 
24 months, clearly showing that the group with better 
operative baseline parameters (Gleason score in biopsy 
and preoperative PSA level) had a worse cancer-specific 
outcome. In both the uni- and multivariate analysis, PSM 
rate and INS were predictors for biochemical recurrence. 
Notably, the well-established long-term predictors Glea-
son score and preoperative PSA did not remain signifi-
cant in the uni- and multivariate analysis after a 2-year 
follow-up, indicating the surgical technique and margin 
status have a higher impact on early RFS. Furthermore, 
no differences in both groups for PSM and RFS rates 
could be observed in pT3 disease (44.4% in INS vs. 48.0% 
in non-INS, p = 0.855), suggesting that the surgical tech-
nique has a limited impact for tumors with extrapros-
tatic extension.
 As commonly observed, in this series most of the pos-
itive margins in pT2 disease were located at the prostatic 
Table 2. Uni- and multivariate Cox regression analysis in pT2 and pT3
Variable Characteristics  Recurrence-free survival
H R 95% CI p
Univariate Cox regression analysis, pT2
Age 1.001 0.915–1.094 0.990
Gleason score (grouped) 5–6 vs. 7 vs. 8–10 0.314 0.214–1.683 0.332
Surgical margin status negative vs. positive 7.045 2.058–24.123 0.002
Preoperative PSA level (grouped) <10 vs. 10 ng/ml 2.430 0.685–8.620 0.169
Surgical technique INS vs. other 3.791 1.001–14.356 0.050
Multivariate Cox regression analysis, pT2
Age 1.051 0.948–1.164 0.347
Gleason score (grouped) 5–6 vs. 7 vs. 8–10 0.618 0.189–2.018 0.425
Surgical margin status negative vs. positive 6.268 1.697–23.149 0.006
Preoperative PSA level (grouped) <10 vs. 10 ng/ml 3.115 0.834–11.636 0.170
Surgical technique INS vs. other 5.363 1.039–27.680 0.045
Univariate Cox regression analysis, pT3
Age 1.030 0.901–1.178 0.656
Gleason score (grouped) 5–6 vs. 7 vs. 8–10 0.493 0.155–1.574 1.574
Surgical margin status negative vs. positive 2.735 0.796–9.398 0.101
Preoperative PSA level (grouped) <10 vs. 10 ng/ml 1.268 0.385–4.174 0.697
Surgical technique INS vs. other 0.465 0.098–2.199 0.301
Multivariate Cox regression analysis, pT3
Age 1.069 0.914–1.250 0.405
Gleason score (grouped) 5–6 vs. 7 vs. 8–10 0.458 0.092–2.281 0.340
Surgical margin status negative vs. positive 1.642 0.438–6.160 0.462
Preoperative PSA level (grouped) <10 vs. 10 ng/ml 0.864 0.213–3.506 0.838
Surgical technique INS vs. other 0.462 0.081–2.630 0.384
p values ≤0.05 are marked in bold.
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apex, where the different fascial layers become less dis-
tinctive and are often mixed with skeletal muscle of the 
sphincter  [26, 27] . This distribution of PSMs is even more 
prominent if INS is performed. Our data indicate that 
during the preparation of the NVB the intrafascial prep-
aration guides the surgeon too close to the prostate tissue 
further increasing the PSM at the apex. In pT3 disease 
mostly a multifocal affection of the surgical margins 
could be observed, indicating the more aggressive char-
acter of these tumors.
 As for many novel techniques, evaluation of a learning 
curve has to be taken in account. For RALRP, different 
groups have reported short learning curves  [28] . In the 
present series, no decline of the PSM rate could be ob-
served over the 27 months ( fig. 2 e). We actually found a 
significant correlation between percentage of INS sur-
gery and percentage of PSMs over time. In our hands, the 
intrafascial technique introduces a systematic error with 
a consistently lower tumor control.
 A limitation of this investigation is the general short-
coming of the pathologic TNM staging. In this study, pa-
tients with pT3 disease were more frequent in non-INS. 
This might be due to patient selection (high-risk patients 
received more often a non-INS). But one has to take in 
account that the diagnosis of pT3 prostate cancer can 
only be made with PF attached to the prostatic specimen 
 [23] . During INS the PF is preserved which can mislead 
the pathologist staging a true pT3 tumor as pT2 with PSM 
 [29] . Therefore, unidentified biologically more aggressive 
pT3 tumors might have shortened the RFS in INS  [29] . 
Further limitation is the lack of randomization due to the 
retrospective manner of this study. Nevertheless, in spite 
of better prognostic parameters, the outcome was re-
versely poor in the INS group.
 The intrafascial technique to preserve the NVB is 
technically feasible but in our hands is correlated with 
significantly higher PSM rates and early biochemical fail-
ure without an improvement over the study period. We 
believe that a possible gain in erectile and continence re-
covery does not justify the significantly decreased tumor 
control. Therefore, we recommend abandoning this tech-
nique for the preparation of the NVB in RALRP in favor 
of a more lateral approach.
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